Funding Rounds
Orasis Pharma Series B round, June 2018
Orasis PharmaceuticalsOrasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Summary
Stage: Series B
Raised Amount: $13.00M
Raised Date: 2018-06-05